Partnering
In line with the company’s current strategy, Nuformix is developing its pipeline of new drug forms for subsequent out-licensing to pharmaceutical companies.
For more information please contact businessdevelopment@nuformix.com
Latest News
RSS FEED- Oct 7th 2010 - Nuformix Expands Lab Facilities & In-house R&D
- Sep 24th 2010 - Nuformix Announces Provisional Patent Application for NX017
- Jul 30th 2010 - NX006 Pre-Clinical Studies Show 220% Increase in Bioavailability
In the 10 months since moving away from an exclusively virtual product development…more
Nuformix are excited to announce the provisional US patent filing for its NX017 product. NX017 is…more
Nuformix has today received the results from pre-clinical studies for its NX006…more